ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
ReShape Lifesciences Inc

ReShape Lifesciences Inc (RSLS)

0,521
-0,0019
( -0,36% )
Aktualisiert: 16:17:57

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,521
Gebot
0,52
Fragen
0,521
Volumen
168.034
0,5163 Tagesbereich 0,541
0,4832 52-Wochen-Bereich 29,00
Marktkapitalisierung
Handelsende
0,5229
Handelsbeginn
0,53
Letzte Trade
100
@
0.521
Letzter Handelszeitpunkt
16:17:58
Finanzvolumen
US$ 88.670
VWAP
0,527692
Durchschnittliches Volumen (3 Mio.)
1.257.465
Ausgegebene Aktien
712.680
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,03
Gewinn pro Aktie (EPS)
-15,98
Erlöse
8,68M
Nettogewinn
-11,39M

Über ReShape Lifesciences Inc

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
ReShape Lifesciences Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker RSLS. The last closing price for ReShape Lifesciences was US$0,52. Over the last year, ReShape Lifesciences shares have traded in a share price range of US$ 0,4832 to US$ 29,00.

ReShape Lifesciences currently has 712.680 shares in issue. The market capitalisation of ReShape Lifesciences is US$372.660,37 . ReShape Lifesciences has a price to earnings ratio (PE ratio) of -0.03.

RSLS Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.1183-18.5046144220.63930.74990.48324165750.57420432CS
4-0.609-53.89380530971.131.280.48325681370.86286994CS
12-3.969-88.39643652564.495.190.483212574651.27462984CS
26-5.079-90.69642857145.67.20.48326112941.62098101CS
52-10.064-95.077940481810.585290.4832203791912.13007253CS
156-4059.479-99.9871674877406044660.48321598322111.29610581CS
260-752.609-99.930822036753.13275500.483214140903022.58347195CS

RSLS - Frequently Asked Questions (FAQ)

What is the current ReShape Lifesciences share price?
The current share price of ReShape Lifesciences is US$ 0,521
How many ReShape Lifesciences shares are in issue?
ReShape Lifesciences has 712.680 shares in issue
What is the market cap of ReShape Lifesciences?
The market capitalisation of ReShape Lifesciences is USD 372,66k
What is the 1 year trading range for ReShape Lifesciences share price?
ReShape Lifesciences has traded in the range of US$ 0,4832 to US$ 29,00 during the past year
What is the PE ratio of ReShape Lifesciences?
The price to earnings ratio of ReShape Lifesciences is -0,03
What is the cash to sales ratio of ReShape Lifesciences?
The cash to sales ratio of ReShape Lifesciences is 0,04
What is the reporting currency for ReShape Lifesciences?
ReShape Lifesciences reports financial results in USD
What is the latest annual turnover for ReShape Lifesciences?
The latest annual turnover of ReShape Lifesciences is USD 8,68M
What is the latest annual profit for ReShape Lifesciences?
The latest annual profit of ReShape Lifesciences is USD -11,39M
What is the registered address of ReShape Lifesciences?
The registered address for ReShape Lifesciences is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the ReShape Lifesciences website address?
The website address for ReShape Lifesciences is www.reshapelifesciences.com
Which industry sector does ReShape Lifesciences operate in?
ReShape Lifesciences operates in the SURGICAL,MED INSTR,APPARATUS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PTPIPetros Pharmaceuticals Inc
US$ 0,1601
(176,99%)
798,12M
OSRHOSR Holdings Inc
US$ 3,125
(95,31%)
59,48M
VVPRVivoPower International PLC
US$ 4,41
(95,13%)
106,1M
SURGSurgePays Inc
US$ 2,365
(71,38%)
56,49M
AQBAquaBounty Technologies Inc
US$ 0,969299
(43,24%)
32,04M
BACKIMAC Holdings Inc
US$ 0,081
(-59,50%)
904,24k
ACRVAcrivon Therapeutics Inc
US$ 3,365
(-37,57%)
690,94k
TNONTenon Medical Inc
US$ 2,63
(-29,87%)
14,41M
ICGIntchains Group Ltd
US$ 2,90
(-29,61%)
96,77k
HUMAHumacyte Inc
US$ 2,035
(-29,22%)
12,59M
PTPIPetros Pharmaceuticals Inc
US$ 0,1601
(176,99%)
798,12M
OCEAOcean Biomedical Inc
US$ 0,08055
(41,81%)
211,19M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,0611
(20,75%)
136,4M
NVDANVIDIA Corporation
US$ 115,38
(-4,40%)
115,52M
VVPRVivoPower International PLC
US$ 4,41
(95,13%)
106,1M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock